Verve Therapeutics logo

Verve Therapeutics share price today

(VERV)

Verve Therapeutics share price is $5.77 & ₹491.59 as on 25 Dec 2024, 2.30 'hrs' IST

$5.77

-0.13

(-2.2%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Verve Therapeutics share price in Dollar and Rupees. Guide to invest in Verve Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Verve Therapeutics. Get details on the Indian mutual funds that are investing in Verve Therapeutics. Get Analyst recommendations and forecasts along with all the Verve Therapeutics's financials.

Verve Therapeutics share price movements

  • Today's Low: $5.65
    Today's High: $5.94

    Day's Volatility :4.97%

  • 52 Weeks Low: $4.31
    52 Weeks High: $19.34

    52 Weeks Volatility :77.74%

Verve Therapeutics Returns

PeriodVerve Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
16.33%
-9.0%
0.0%
6 Months
21.22%
-4.6%
0.0%
1 Year
-60.67%
3.0%
0.0%
3 Years
-85.58%
0.0%
-21.1%

Verve Therapeutics Key Statistics

in dollars & INR

Previous Close
$5.9
Open
$5.93
Today's High
$5.94
Today's Low
$5.645
Market Capitalization
$488.5M
Today's Volume
$526.4K
52 Week High
$19.34
52 Week Low
$4.305
Revenue TTM
$24.4M
EBITDA
$-220.0M
Earnings Per Share (EPS)
$-2.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-40.67%

How to invest in Verve Therapeutics from India?

It is very easy for Indian residents to invest directly in Verve Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Verve Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Verve Therapeutics or VERV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Verve Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Verve Therapeutics shares which would translate to 0.148 fractional shares of Verve Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Verve Therapeutics, in just a few clicks!

Returns in Verve Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Verve Therapeutics investment value today

Current value as on today

₹41,571

Returns

₹58,429

(-58.43%)

Returns from Verve Therapeutics Stock

₹60,668 (-60.67%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Verve Therapeutics

52%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Verve Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 52% more investors are searching Verve Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Verve Therapeutics

  • Alphabet Inc

    14.59%

  • BlackRock Inc

    7.82%

  • Millennium Management LLC

    5.86%

  • State Street Corp

    5.02%

  • Vanguard Group Inc

    4.73%

  • Casdin Capital, LLC

    4.72%

Analyst Recommendation on Verve Therapeutics

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Verve Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
13
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Verve Therapeutics

What analysts predicted

Upside of 354.11%

Current:

$5.77

Target:

$26.20

Insights on Verve Therapeutics

  • Price Movement

    In the last 7 days, VERV stock has moved up by 11.8%
  • Increasing Revenue

    Revenue is up for the last 9 quarters, 929.0K → 6.86M (in $), with an average increase of 21.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, -45.75M → -50.13M (in $), with an average decrease of 2.3% per quarter
  • VERV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 88.2%
  • VERV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 111.2%
  • Price to Sales

    ForVERV every $1 of sales, investors are willing to pay $19.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Verve Therapeutics Technicals Summary

Sell

Neutral

Buy

Verve Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Verve Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Verve Therapeutics Inc
8.66%
21.22%
-60.67%
-85.58%
-87.46%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Verve Therapeutics Inc
2.34
NA
NA
-2.45
-0.41
-0.22
NA
6.01
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Verve Therapeutics Inc
Buy
$488.5M
-87.46%
2.34
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Verve Therapeutics

verve therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. the company brings together human genetics analysis and gene editing – two of the biggest breakthroughs in 21st century biomedicine – to develop transformative therapies for coronary heart disease. verve is developing medicines, administered once in life, to safely edit the genome of adults to permanently lower ldl cholesterol and triglyceride levels and thereby treat coronary heart disease. founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, verve is backed by a top-tier syndicate of investors, including gv (formerly google ventures), arch venture partners, f-prime capital, biomatics capital, wellington management, casdin capital, and partners innovation fund. the company was recognized as a "2020 best places to work" by the boston business journal. verve is headquartered in cambridge, massachusetts.
Organization
Verve Therapeutics
Employees
255
CEO
Dr. Sekar Kathiresan M.D.
Industry
Services

Management People of Verve Therapeutics

NameTitle
Dr. Sekar Kathiresan M.D.
Co-Founder, CEO & Director
Ms. Allison Dorval CPA
CFO & Principal Accounting Officer
Mr. Andrew D. Ashe J.D.
President, COO & General Counsel
Dr. Kiran Musunuru M.D., M.P.H., Ph.D.
Co-Founder
Dr. J. Keith Joung M.D., Ph.D.
Co-Founder
Dr. Anthony Philippakis M.D., Ph.D.
Co-Founder & Scientific Advisory Board Member
Dr. Barry S. Ticho FACC, M.D., Ph.D.
Co-Founder
Mr. Issi Rozen M.B.A.
Co-Founder & Strategic Advisor
Dr. Troy Lister Ph.D.
Chief Scientific Officer
Ms. Joan Nickerson M.B.A.
Chief Administrative Officer

Important FAQs about investing in Verve Therapeutics from India :

What is Verve Therapeutics share price today?

Verve Therapeutics share price today stands at $5.77, Open: $5.93 ; Previous Close: $5.90 ; High: $5.94 ; Low: $5.65 ; 52 Week High: $19.34 ; 52 Week Low: $4.31. The stock opens at $5.93, after a previous close of $5.90. The stock reached a daily high of $5.94 and a low of $5.65, with a 52-week high of $19.34 and a 52-week low of $4.31.

Can Indians buy Verve Therapeutics shares?

Yes, Indians can invest in the Verve Therapeutics (VERV) from India.

With INDmoney, you can buy Verve Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Verve Therapeutics at zero transaction cost.

How can I buy Verve Therapeutics shares from India?

It is very easy to buy Verve Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Verve Therapeutics be purchased?

Yes, you can buy fractional shares of Verve Therapeutics with INDmoney app.

What are the documents required to start investing in Verve Therapeutics stocks?

To start investing in Verve Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Verve Therapeutics

Today’s highest price of Verve Therapeutics (VERV) is $5.94.

Today’s lowest price of Verve Therapeutics (VERV) is $5.65.

What is today's market capitalisation of Verve Therapeutics

Today's market capitalisation of Verve Therapeutics VERV is 488.5M

What is the 52 Week High and Low Range of Verve Therapeutics

  • 52 Week High

    $19.34

  • 52 Week Low

    $4.31

What are the historical returns of Verve Therapeutics?

  • 1 Month Returns

    8.66%

  • 3 Months Returns

    21.22%

  • 1 Year Returns

    -60.67%

  • 5 Years Returns

    -87.46%

Who is the Chief Executive Officer (CEO) of Verve Therapeutics

Dr. Sekar Kathiresan M.D. is the current Chief Executive Officer (CEO) of Verve Therapeutics.